Over 15 years working with market access, reimbursement and pricing within the pharma and medical device industries. Built on a foundation from in-house roles for Astra Zeneca and Novo Nordisk, along with consultancy through Synergus and European Health Economics. Market Access Sweden was established in 2010 to provide Nordic specific expertise directly to pharma/medical device clients, or via international agency vendors Areas of support: Reimbursement applications Market access environmental analysis Pricing strategy Value communication Tender/Negotiation support Therapeutic Experience: Diabetes Neurology Oncology Hepatitis Multiple Sclerosis Hormone Replacement Therapy Keywords: TLV, NOMA, HILA, DKMA, Biosimilar, Medical Devices, Pharmaceutical Drugs, VARA, Orphan Drug, Särläkemedel, Pricing